The global companion animal health market size is calculated at USD 9.71 billion in 2025 and is forecasted to reach around USD 18.75 billion by 2034, accelerating at a CAGR of 7.58% from 2025 to 2034. The North America market size surpassed USD 3.52 billion in 2024 and is expanding at a CAGR of 7.72% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Companion Animal Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Companion Animal Health Market, by Animal Type
8.1.1. Animal Type
8.1.1.1. Market Revenue and Forecast
8.1.2. Cats
8.1.2.1. Market Revenue and Forecast
8.1.3. Eqiune
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast
9.1. Companion Animal Health Market, by Product
9.1.1. Vaccines
9.1.1.1. Market Revenue and Forecast
9.1.2. Pharmaceuticals
9.1.2.1. Market Revenue and Forecast
9.1.3. OTC
9.1.3.1. Market Revenue and Forecast
9.1.4. Prescription
9.1.4.1. Market Revenue and Forecast
9.1.4. Feed Additives
9.1.4.1. Market Revenue and Forecast
9.1.4. Diagnostics
9.1.4.1. Market Revenue and Forecast
9.1.4. Others
9.1.4.1. Market Revenue and Forecast
10.1. Companion Animal Health Market, by Distribution Channel
10.1.1. Retail
10.1.1.1. Market Revenue and Forecast
10.1.2. E-commerce
10.1.2.1. Market Revenue and Forecast
10.1.3. Hospital pharmacies
10.1.3.1. Market Revenue and Forecast
10.1.4. Cancer Research
10.1.4.1. Market Revenue and Forecast
11.1. Companion Animal Health Market, by End-use
11.1.1. Point-of-care/In-house testing
11.1.1.1. Market Revenue and Forecast
11.1.2. Hospitals & clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
11.1.4. Industrial
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Animal Type
12.1.2. Market Revenue and Forecast, by Product
12.1.3. Market Revenue and Forecast, by Distribution Channel
12.1.4. Market Revenue and Forecast, by End-use
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Animal Type
12.1.5.2. Market Revenue and Forecast, by Product
12.1.5.3. Market Revenue and Forecast, by Distribution Channel
12.1.5.4. Market Revenue and Forecast, by End-use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Animal Type
12.1.6.2. Market Revenue and Forecast, by Product
12.1.6.3. Market Revenue and Forecast, by Distribution Channel
12.1.6.4. Market Revenue and Forecast, by End-use
12.2. Europe
12.2.1. Market Revenue and Forecast, by Animal Type
12.2.2. Market Revenue and Forecast, by Product
12.2.3. Market Revenue and Forecast, by Distribution Channel
12.2.4. Market Revenue and Forecast, by End-use
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Animal Type
12.2.5.2. Market Revenue and Forecast, by Product
12.2.5.3. Market Revenue and Forecast, by Distribution Channel
12.2.5.4. Market Revenue and Forecast, by End-use
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Animal Type
12.2.6.2. Market Revenue and Forecast, by Product
12.2.6.3. Market Revenue and Forecast, by Distribution Channel
12.2.6.4. Market Revenue and Forecast, by End-use
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Animal Type
12.2.7.2. Market Revenue and Forecast, by Product
12.2.7.3. Market Revenue and Forecast, by Distribution Channel
12.2.7.4. Market Revenue and Forecast, by End-use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Animal Type
12.2.8.2. Market Revenue and Forecast, by Product
12.2.8.3. Market Revenue and Forecast, by Distribution Channel
12.2.8.4. Market Revenue and Forecast, by End-use
12.3. APAC
12.3.1. Market Revenue and Forecast, by Animal Type
12.3.2. Market Revenue and Forecast, by Product
12.3.3. Market Revenue and Forecast, by Distribution Channel
12.3.4. Market Revenue and Forecast, by End-use
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Animal Type
12.3.5.2. Market Revenue and Forecast, by Product
12.3.5.3. Market Revenue and Forecast, by Distribution Channel
12.3.5.4. Market Revenue and Forecast, by End-use
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Animal Type
12.3.6.2. Market Revenue and Forecast, by Product
12.3.6.3. Market Revenue and Forecast, by Distribution Channel
12.3.6.4. Market Revenue and Forecast, by End-use
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Animal Type
12.3.7.2. Market Revenue and Forecast, by Product
12.3.7.3. Market Revenue and Forecast, by Distribution Channel
12.3.7.4. Market Revenue and Forecast, by End-use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Animal Type
12.3.8.2. Market Revenue and Forecast, by Product
12.3.8.3. Market Revenue and Forecast, by Distribution Channel
12.3.8.4. Market Revenue and Forecast, by End-use
12.4. MEA
12.4.1. Market Revenue and Forecast, by Animal Type
12.4.2. Market Revenue and Forecast, by Product
12.4.3. Market Revenue and Forecast, by Distribution Channel
12.4.4. Market Revenue and Forecast, by End-use
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Animal Type
12.4.5.2. Market Revenue and Forecast, by Product
12.4.5.3. Market Revenue and Forecast, by Distribution Channel
12.4.5.4. Market Revenue and Forecast, by End-use
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Animal Type
12.4.6.2. Market Revenue and Forecast, by Product
12.4.6.3. Market Revenue and Forecast, by Distribution Channel
12.4.6.4. Market Revenue and Forecast, by End-use
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Animal Type
12.4.7.2. Market Revenue and Forecast, by Product
12.4.7.3. Market Revenue and Forecast, by Distribution Channel
12.4.7.4. Market Revenue and Forecast, by End-use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Animal Type
12.4.8.2. Market Revenue and Forecast, by Product
12.4.8.3. Market Revenue and Forecast, by Distribution Channel
12.4.8.4. Market Revenue and Forecast, by End-use
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Animal Type
12.5.2. Market Revenue and Forecast, by Product
12.5.3. Market Revenue and Forecast, by Distribution Channel
12.5.4. Market Revenue and Forecast, by End-use
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Animal Type
12.5.5.2. Market Revenue and Forecast, by Product
12.5.5.3. Market Revenue and Forecast, by Distribution Channel
12.5.5.4. Market Revenue and Forecast, by End-use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Animal Type
12.5.6.2. Market Revenue and Forecast, by Product
12.5.6.3. Market Revenue and Forecast, by Distribution Channel
12.5.6.4. Market Revenue and Forecast, by End-use
13.1. Mars Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Embark Veterinary, Inc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. SYNLAB
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. NationWide Laboratories
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. IVC Evidensia
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. CVS Group Plc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Greencross Vets
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Zoetis Services LLC
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. IDEXX Laboratories, Inc.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. The Animal Medical Center
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample